StockData
Annovis Bio, Inc. logo

Annovis Bio, Inc. (ANVS) stock

ANVSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.74−0.01 (-0.91%)

Close on Nov 17, 2026Market cap $31.66MP/E –Yield –

Annovis Bio r&d expenses

Research and development expenses are spending on new products and technology.

Annovis Bio's R&D Expenses for the twelve months ending Jun 30, 2026 was $43.77M, up 145.1% year over year. For fiscal 2025 it was $25.22M, up 26.1% from the year before. The highest annual figure on record is $38.79M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$25.22M+26.1%
FY2024Dec 31, 2024$20.00M-48.5%
FY2023Dec 31, 2023$38.79M+134.9%
FY2022Dec 31, 2022$16.52M+94.8%
FY2021Dec 31, 2021$8.48M+177.6%
FY2020Dec 31, 2020$3.05M+293.4%
FY2019Dec 31, 2019$776.26K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$12.01M+132.6%
Q1 FY2026Mar 31, 2026$16.72M+233.6%
Q4 FY2025Dec 31, 2025$8.75M+75.1%
Q3 FY2025Sep 30, 2025$6.29M+133.9%
Q2 FY2025Jun 30, 2025$5.16M-10.8%
Q1 FY2025Mar 31, 2025$5.01M-23.1%
Q4 FY2024Dec 31, 2024$5.00M-43.9%
Q3 FY2024Sep 30, 2024$2.69M-80.6%
Q2 FY2024Jun 30, 2024$5.79M-30.0%
Q1 FY2024Mar 31, 2024$6.51M-16.3%
Q4 FY2023Dec 31, 2023$8.90M+43.4%
Q3 FY2023Sep 30, 2023$13.84M+235.6%
Q2 FY2023Jun 30, 2023$8.26M+104.8%
Q1 FY2023Mar 31, 2023$7.79M+262.2%
Q4 FY2022Dec 31, 2022$6.21M+115.3%
Q3 FY2022Sep 30, 2022$4.12M+198.6%
Q2 FY2022Jun 30, 2022$4.03M+121.1%
Q1 FY2022Mar 31, 2022$2.15M-10.0%
Q4 FY2021Dec 31, 2021$2.88M+104.2%
Q3 FY2021Sep 30, 2021$1.38M+92.1%
Q2 FY2021Jun 30, 2021$1.82M+113.0%
Q1 FY2021Mar 31, 2021$2.39M+3496.3%
Q4 FY2020Dec 31, 2020$1.41M+85.3%
Q3 FY2020Sep 30, 2020$718.90K+35612.8%
Q2 FY2020Jun 30, 2020$856.48K+14080.1%
Q1 FY2020Mar 31, 2020$66.45K+1003.6%
Q4 FY2019Dec 31, 2019$762.18K–
Q3 FY2019Sep 30, 2019$2.01K–
Q2 FY2019Jun 30, 2019$6.04K–
Q1 FY2019Mar 31, 2019$6.02K–

More Annovis Bio figures

See a number that looks wrong?